ATE553196T1 - Zusammensetzung und verfahren zur modulation von zellproliferation und zelltod - Google Patents
Zusammensetzung und verfahren zur modulation von zellproliferation und zelltodInfo
- Publication number
- ATE553196T1 ATE553196T1 AT08710243T AT08710243T ATE553196T1 AT E553196 T1 ATE553196 T1 AT E553196T1 AT 08710243 T AT08710243 T AT 08710243T AT 08710243 T AT08710243 T AT 08710243T AT E553196 T1 ATE553196 T1 AT E553196T1
- Authority
- AT
- Austria
- Prior art keywords
- composition
- cell proliferation
- modulating
- cell death
- cell
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 230000030833 cell death Effects 0.000 title abstract 2
- 230000004663 cell proliferation Effects 0.000 title abstract 2
- 108700011259 MicroRNAs Proteins 0.000 abstract 1
- 230000001419 dependent effect Effects 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]
- C12N2310/141—MicroRNAs, miRNAs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2330/00—Production
- C12N2330/10—Production naturally occurring
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US90352607P | 2007-02-27 | 2007-02-27 | |
| PCT/IL2008/000243 WO2008104974A2 (en) | 2007-02-27 | 2008-02-26 | Composition and methods for modulating cell proliferation and cell death |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE553196T1 true ATE553196T1 (de) | 2012-04-15 |
Family
ID=39608185
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT08710243T ATE553196T1 (de) | 2007-02-27 | 2008-02-26 | Zusammensetzung und verfahren zur modulation von zellproliferation und zelltod |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US8765702B2 (de) |
| EP (1) | EP2126078B2 (de) |
| AT (1) | ATE553196T1 (de) |
| AU (1) | AU2008220438A1 (de) |
| CA (1) | CA2699418A1 (de) |
| WO (1) | WO2008104974A2 (de) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007016548A2 (en) * | 2005-08-01 | 2007-02-08 | The Ohio State University Research Foundation | Micro-rna-based methods and compositions for the diagnosis, prognosis and treatment of breast cancer |
| US8481505B2 (en) * | 2005-09-12 | 2013-07-09 | The Ohio State University Research Foundation | Compositions and methods for the diagnosis and therapy of BCL2-associated cancers |
| WO2007081680A2 (en) * | 2006-01-05 | 2007-07-19 | The Ohio State University Research Foundation | Microrna expression abnormalities in pancreatic endocrine and acinar tumors |
| EP2484782B1 (de) | 2006-01-05 | 2015-11-18 | The Ohio State University Research Foundation | Verfahren und Zusammensetzungen auf Mikro-RNA-Basis zur Diagnose und Behandlung von soliden Krebs |
| ES2446362T3 (es) | 2006-03-20 | 2014-03-07 | The Ohio State University Research Foundation | Huellas de microARN durante megacariocipoyesis humana |
| ES2425387T3 (es) | 2006-07-13 | 2013-10-15 | The Ohio State University Research Foundation | Mir-106a para diagnosticar adenocarcinoma de colon de pronóstico de supervivencia pobre |
| JP2010516291A (ja) | 2007-01-31 | 2010-05-20 | ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション | 急性骨髄性白血病(aml)の診断、予後及び治療のためのマイクロrnaに基づく方法及び組成物 |
| US9006206B2 (en) * | 2007-02-27 | 2015-04-14 | Rosetta Genomics Ltd. | Composition and methods for modulating cell proliferation and cell death |
| US8399248B2 (en) | 2007-05-03 | 2013-03-19 | Merck Sharp & Dohme Corp. | Methods of using MIR34 as a biomarker for TP53 functional status |
| US8053186B2 (en) | 2007-06-15 | 2011-11-08 | The Ohio State University Research Foundation | Oncogenic ALL-1 fusion proteins for targeting Drosha-mediated microRNA processing |
| EP2173911B1 (de) * | 2007-07-31 | 2014-06-18 | The Ohio State University Research Foundation | Verfahren zur methylierungsreversion mittels abzielen auf dnmt3a und dnmt3b |
| EP2653561B1 (de) | 2007-08-03 | 2016-03-02 | The Ohio State University Research Foundation | Ultrakonservierte Bereiche zur Codierung von ncRNA |
| EP3028708A1 (de) * | 2007-08-22 | 2016-06-08 | The Ohio State University Research Foundation | Verfahren und zusammensetzungen zur induzierung von epha7-deregulierung und erk-phosphorlylierung bei humaner akuter leukämie |
| EP3138926A3 (de) * | 2007-09-06 | 2017-04-05 | The Ohio State University Research Foundation | Mirna-signaturen in menschlichem ovarialkarzinom |
| EP2212440A4 (de) * | 2007-10-11 | 2011-04-06 | Univ Ohio State Res Found | Verfahren und zusammensetzungen zur diagnose und behandlung von adenokarzinomen der speiseröhre |
| WO2009055773A2 (en) | 2007-10-26 | 2009-04-30 | The Ohio State University Research Foundation | Methods for identifying fragile histidine triad (fhit) interaction and uses thereof |
| EP2225396A4 (de) * | 2007-11-30 | 2011-03-02 | Univ Ohio State Res Found | Mikro-rna-expressionsprofilerstellung und abzielen darauf in peripherem blut bei lungenkrebs |
| JP5662166B2 (ja) * | 2008-02-28 | 2015-01-28 | ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイションThe Ohio State University Research Foundation | 胃癌の診断、予後診断及び治療のためのマイクロrnaに基づいた方法及び組成物 |
| CA2734179A1 (en) * | 2008-08-12 | 2010-02-18 | The Ohio State University Research Foundation | Micro-rna-based compositions and methods for the diagnosis, prognosis and treatment of multiple myeloma |
| EP2504452A4 (de) | 2009-11-23 | 2014-06-11 | Univ Ohio State Res Found | Materialien und verfahren zur beeinflussung des wachstums, der migration und der invasion von tumorzellen |
| US8846631B2 (en) | 2010-01-14 | 2014-09-30 | Regulus Therapeutics Inc. | MicroRNA compositions and methods |
| US20130150430A1 (en) * | 2010-08-04 | 2013-06-13 | The Ohio State University | Methods for Impairing the P53/HDM2 Auto-Regulatory Loop in Multiple Myeloma Development Using mIR-192, mIR-194 and mIR-215 |
| WO2012065049A1 (en) | 2010-11-12 | 2012-05-18 | The Ohio State University Research Foundation | Materials and methods related to microrna-21, mismatch repair, and colorectal cancer |
| CA2817982C (en) | 2010-11-15 | 2020-06-30 | The Regents Of The University Of Michigan | Controlled release mucoadhesive systems |
| JP2014509852A (ja) | 2011-03-07 | 2014-04-24 | ジ・オハイオ・ステート・ユニバーシティ | マイクロRNA−155(miR−155)により誘導される変異誘発活性は炎症および癌を結び付ける |
| CA2852066A1 (en) | 2011-10-14 | 2013-04-18 | The Ohio State University | Methods and materials related to ovarian cancer |
| EP2790735A4 (de) | 2011-12-13 | 2015-12-09 | Ohio State Innovation Foundation | Verfahren und zusammensetzungen im zusammenhang mit mir-21 und mir-29a, exosomerhemmung und krebsmetastasen |
| JP2015511121A (ja) | 2012-01-20 | 2015-04-16 | ジ・オハイオ・ステート・ユニバーシティ | 浸潤性および予後に関する乳がんバイオマーカーシグネチャー |
| US20160145628A1 (en) | 2013-06-18 | 2016-05-26 | Ramot At Tel-Aviv University Ltd. | Nanocarrier system for micrornas and uses thereof |
| US10722599B2 (en) | 2015-02-04 | 2020-07-28 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Lipid assemblies and uses thereof and some pH and electrostatic modulating lipids to be used in said assemblies |
| US11584932B2 (en) | 2016-11-01 | 2023-02-21 | The Research Foundation For The State University Of New York | 5-halouracil-modified microRNAs and their use in the treatment of cancer |
| CN113041255B (zh) * | 2021-04-13 | 2022-10-11 | 上海中医药大学 | 一种新发现miRNA–mRNA调控轴介导肺腺癌NCI-H1299细胞焦亡的方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5034506A (en) | 1985-03-15 | 1991-07-23 | Anti-Gene Development Group | Uncharged morpholino-based polymers having achiral intersubunit linkages |
| US5235033A (en) | 1985-03-15 | 1993-08-10 | Anti-Gene Development Group | Alpha-morpholino ribonucleoside derivatives and polymers thereof |
| CA2135646A1 (en) | 1992-05-11 | 1993-11-25 | Kenneth G. Draper | Method and reagent for inhibiting viral replication |
| JPH07509133A (ja) | 1992-07-17 | 1995-10-12 | リボザイム・ファーマシューティカルズ・インコーポレイテッド | 動物疾患の処置のための方法および剤 |
| US6395713B1 (en) | 1997-07-23 | 2002-05-28 | Ribozyme Pharmaceuticals, Inc. | Compositions for the delivery of negatively charged molecules |
| AU8525098A (en) | 1997-07-24 | 1999-02-16 | Inex Pharmaceuticals Corporation | Liposomal compositions for the delivery of nucleic acid catalysts |
| US6506559B1 (en) | 1997-12-23 | 2003-01-14 | Carnegie Institute Of Washington | Genetic inhibition by double-stranded RNA |
| EP2669377A3 (de) | 2003-04-17 | 2015-10-14 | Alnylam Pharmaceuticals Inc. | Modifizierte iRNA-Wirkstoffe |
| WO2005013901A2 (en) * | 2003-07-31 | 2005-02-17 | Isis Pharmaceuticals, Inc. | Oligomeric compounds and compositions for use in modulation of small non-coding rnas |
| EP1713938A2 (de) | 2004-02-09 | 2006-10-25 | Thomas Jefferson University | Diagnose und behandlung von krebserkrankungen mit oder nahe mit krebs in zusammenhang stehenden chromosomalen merkmalen lokalisierter microrna |
| US20050182005A1 (en) | 2004-02-13 | 2005-08-18 | Tuschl Thomas H. | Anti-microRNA oligonucleotide molecules |
| EP2471924A1 (de) * | 2004-05-28 | 2012-07-04 | Asuragen, INC. | Verfahren und Zusammensetzungen mit microRNA |
| ES2534300T3 (es) | 2004-11-12 | 2015-04-21 | Asuragen, Inc. | Procedimientos y composiciones que implican miARN y moléculas inhibidoras de miARN |
| WO2007016548A2 (en) | 2005-08-01 | 2007-02-08 | The Ohio State University Research Foundation | Micro-rna-based methods and compositions for the diagnosis, prognosis and treatment of breast cancer |
| JP2010516249A (ja) | 2007-01-17 | 2010-05-20 | ザ・ジョンズ・ホプキンス・ユニバーシティ | 腫瘍治療のためのミクロrnaに関する組成物及び方法 |
-
2008
- 2008-02-26 WO PCT/IL2008/000243 patent/WO2008104974A2/en not_active Ceased
- 2008-02-26 AT AT08710243T patent/ATE553196T1/de active
- 2008-02-26 US US12/528,690 patent/US8765702B2/en not_active Expired - Fee Related
- 2008-02-26 CA CA2699418A patent/CA2699418A1/en not_active Abandoned
- 2008-02-26 EP EP08710243.0A patent/EP2126078B2/de not_active Not-in-force
- 2008-02-26 AU AU2008220438A patent/AU2008220438A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP2126078B2 (de) | 2023-01-04 |
| US20100104662A1 (en) | 2010-04-29 |
| WO2008104974A2 (en) | 2008-09-04 |
| US8765702B2 (en) | 2014-07-01 |
| CA2699418A1 (en) | 2008-09-04 |
| AU2008220438A1 (en) | 2008-09-04 |
| EP2126078A2 (de) | 2009-12-02 |
| WO2008104974A3 (en) | 2009-03-05 |
| EP2126078B1 (de) | 2012-04-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2008104974A3 (en) | Composition and methods for modulating cell proliferation and cell death | |
| ATE533838T1 (de) | Verfahren zur verbesserten einführung von dna in bakterienzellen | |
| BR112013007862A2 (pt) | ácidos nucleicos manipulados e métodos de uso dos mesmos. | |
| GEP20217251B (en) | Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription | |
| ATE430480T1 (de) | Verfahren zur herstellung von nährmittelzusammensetzungen | |
| ATE553195T1 (de) | Zusammensetzungen und verfahren mit rna- interferenz opr3-ähnlichem gen zur kontrolle von nematoden | |
| EP4010004A4 (de) | Zusammensetzungen und verfahren zur modulation von genexpression | |
| EP4031577A4 (de) | Verfahren zur züchtung von natürlichen killerzellen gegen bcma-positive tumoren | |
| EP2061482A4 (de) | Verfahren zur modulation der expression von epidermalem wachstumsfaktor-rezeptor (egfr) mit mirna | |
| EP4048792A4 (de) | Zusammensetzungen und verfahren zur editierung des cdkl5-gens | |
| EP2603781A4 (de) | System und verfahren zur quantifizierung der farbe und intensität von lichtquellen | |
| EP3980068A4 (de) | Zellkulturverfahren und zusammensetzungen zur produktion von antikörpern | |
| EA201101478A1 (ru) | Композиции и способы модулирования связывания ретинола с ретинолсвязывающим белком 4 (rbp4) | |
| ATE480615T1 (de) | Verfahren zur proliferation von stammzellen | |
| EA200970407A1 (ru) | Ингибиторы киназ mapk/erk | |
| EP4415728A4 (de) | Zusammensetzungen und verfahren zur herstellung von t-zellen | |
| EP2266633A4 (de) | Gasdekompositionsvorrichtung und verfahren zur dekomposition von gas | |
| EP3511410A4 (de) | Medium zur kultivierung von stammzellen, verfahren zur kultivierung von stammzellen, stammzellenwachstumsförderer und zusammensetzung und verfahren zur herstellung davon | |
| EP4103691C0 (de) | Zellkultursubstrate, verfahren und verwendungen davon | |
| EP2133158A4 (de) | Verfahren zur entgiftung von asbest | |
| EP4326878A4 (de) | Zusammensetzungen und verfahren zur modulierung von sos-genexpressionen | |
| EP4073250A4 (de) | Zusammensetzungen und verfahren zur amplifikation von nukleinsäuren | |
| DE102005053064A1 (de) | Verfahren zur Herstellung von Pfropfpolymerisaten | |
| ATE540755T1 (de) | Verwendung von katalysatorzusammensetzungen und verfahren zur oxychlorierung | |
| EP2118305A4 (de) | Verfahren und kits zur dna-amplifikation |